Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 368.55
-3.75 (-1.01%)
At close: Feb 4, 2026
Biocon Employees
Biocon had 16,420 employees as of September 30, 2025. The number of employees increased by 105 or 0.64% compared to the previous year.
Employees
16,420
Change
105
Growth
0.64%
Revenue / Employee
10.03M INR
Profits / Employee
295.68K INR
Market Cap
596.45B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 16,420 | 105 | 0.64% |
| Mar 31, 2024 | 16,315 | -230 | -1.39% |
| Mar 31, 2023 | 16,545 | 1,545 | 10.30% |
| Mar 31, 2022 | 15,000 | 1,500 | 11.11% |
| Mar 31, 2021 | 13,500 | 891 | 7.07% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Panacea Biotec | 2,149 |
| Concord Biotech | 1,571 |
| OneSource Specialty Pharma | 1,412 |
| Dishman Carbogen Amcis | 1,106 |
| Haleos Labs | 592 |
| Zota Health Care | 519 |
| Supriya Lifescience | 515 |
| Lyka Labs | 499 |
Biocon News
- 3 days ago - Biocon shares in focus as FM Sitharaman announces Rs 100 billion allocation for biopharma sector - Business Upturn
- 23 days ago - Pharma sector stocks down today: Divi’s Laboratories falls nearly 3%, Biocon drops 1.09%, Sun Pharma down 0.45% - Business Upturn
- 4 weeks ago - Top stocks to watch today, January 7: Titan Company, Mahindra, Godrej Consumer, Jubilant, Biocon and more - Business Upturn
- 5 weeks ago - Biocon employee found dead on Bengaluru campus, police probe underway - Business Upturn
- 5 weeks ago - Biocon staffer jumps to death from office building in Bengaluru - The Times of India
- 5 weeks ago - Biocon Employee, 26, Found Dead At Bengaluru Office - NDTV
- 6 weeks ago - Ajanta Pharma shares jump over 4% after signing in-licensing agreement with Biocon - Business Upturn
- 6 weeks ago - Biocon signs out-licensing deal with Ajanta Pharma to market Semaglutide in overseas markets - Business Upturn